Information  X 
Enter a valid email address

Poolbeg Pharma Plc Ord 0.02p (POLB)

Date Time Source Announcement
29 Jul 2022 7:00 am
RNS
Appointment of Joint Broker
20 Jul 2022 7:00 am
RNS
POLB001 human challenge clinical trial to commence
12 Jul 2022 2:06 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
27 Jun 2022 7:00 am
RNS
Project update for AI model of RSV data
21 Jun 2022 4:40 pm
RNS
Second Price Monitoring Extn
  4:36 pm
RNS
Price Monitoring Extension
26 May 2022 2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  7:00 am
RNS
US patents granted for POLB 001 and POLB 002
25 May 2022 4:40 pm
RNS
Second Price Monitoring Extn
  4:35 pm
RNS
Price Monitoring Extension
23 May 2022 1:01 pm
RNS
TR-1: Notification of major interest in shares
12 May 2022 7:00 am
RNS
GMP manufacturing contract signed
11 May 2022 7:00 am
RNS
Attendance at European Melioidosis Congress
27 Apr 2022 7:00 am
RNS
Distribution in Specie update
14 Apr 2022 7:00 am
RNS
Key POLB 002 European Patent Granted
11 Apr 2022 7:00 am
RNS
Distribution in Specie Shareholders
04 Apr 2022 12:26 pm
RNS
Result of AGM
31 Mar 2022 7:00 am
RNS
POLB001 Update - Clinical Trial Agreement Signed
30 Mar 2022 7:00 am
RNS
Commencement of trading on US OTCQB market
24 Mar 2022 7:00 am
RNS
AI deal signed with CytoReason
09 Mar 2022 7:00 am
RNS
Notice of AGM
03 Mar 2022 7:00 am
RNS
Final Results
28 Feb 2022 7:00 am
RNS
Notice of Results
24 Feb 2022 7:00 am
RNS
Artificial Intelligence deal with OneThree Biotech
31 Jan 2022 7:00 am
RNS
Confirmation of vaccine platform licence execution
17 Jan 2022 7:00 am
RNS
Exclusive license of RNA-based immunotherapy asset
16 Dec 2021 7:00 am
RNS
Poolbeg to develop oral vaccine delivery platform
06 Dec 2021 7:00 am
RNS
Poolbeg signs option for new vaccine candidate
25 Nov 2021 7:00 am
RNS
Scientific Advisory Board Appointment
18 Nov 2021 7:00 am
RNS
Update on POLB 001 Clinical Development
14 Oct 2021 9:05 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
  7:00 am
RNS
PredictViral Patent Update
07 Oct 2021 7:00 am
RNS
RNA sequencing ahead of AI analysis programme
13 Sep 2021 7:00 am
RNS
September and October Investor conferences
07 Sep 2021 7:00 am
RNS
POLB001 US Patent Update
23 Aug 2021 9:06 am
RNS
Second Price Monitoring Extn
  9:00 am
RNS
Price Monitoring Extension
04 Aug 2021 11:30 am
RNS
Holding(s) in Company
23 Jul 2021 1:26 pm
RNS
TR-1
19 Jul 2021 7:00 am
RNS
Admission to AIM

a d v e r t i s e m e n t